Last update 07 Mar 2025

S-Biomedic NV

Subsidiary Company|
2014|
Belgium
|
www.sbiomedic.com

Overview

Basic Info

Introduction
S-Biomedic NV, a company based in Beerse, Belgium and owned by maxingvest AG, specializes in creating technology that can manipulate the skin microbiome by transplanting helpful bacteria onto the skin. On December 16, 2022, S-Biomedic NV was acquired by Beiersdorf AG.

Tags

Nervous System Diseases
Other Diseases
Neural stem cell therapy

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Nervous System Diseases1
Top 5 Drug TypeCount
Neural stem cell therapy1

Related

1
Drugs associated with S-Biomedic NV
Neural precursor cell therapy (S Biomedics)
Target-
Mechanism
Cell replacements
Active Org.
S-Biomedic NV
Originator Org.
S-Biomedic NV
Active Indication
Spinal Cord Injuries
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with S-Biomedic NV
Login to view more data
0 Patents (Medical) associated with S-Biomedic NV
Login to view more data
100 Deals associated with S-Biomedic NV
Login to view more data
100 Translational Medicine associated with S-Biomedic NV
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 19 Apr 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Neural precursor cell therapy (S Biomedics)
Spinal Cord Injuries
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free